JNJ vs ZETA · P/E 17, rev $49.37B vs rev $839.1M
Johnson & Johnson (JNJ) versus Zeta Global Holdings Corp (ZETA) — a side-by-side from cached financials, not a winner call.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Zeta Global Holdings Corp (ZETA) is a software - infrastructure company listed on NYSE.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Latest reported ZETA revenue for 2026-06-30 was $839.1M. Net income was -$5.1M. ZETA currently screens at market cap $4.50B.
JNJ currently screens at market cap $375.37B and trailing P/E 17.4. ZETA currently screens at market cap $4.50B.
Not investment advice. Open the JNJ and ZETA stock pages for the full models.
Not investment advice.